Home / Ifosfamide / Austria
AT ATC L01AA06 · updated 2 Nov 2026
Ifosfamide shortage in Austria
Is there an Ifosfamide shortage in Austria?
Yes. As of 2 Nov 2026, 2 Ifosfamide products are reported short in Austria, the first since 26 Jan 2026. The company estimate for the return is 31 Mar 2027. Main reason: manufacturing problem.
Also short in United States, Germany, France, Italy, Belgium, Switzerland, Czechia, Norway, Sweden, Japan, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Holoxan 1 g - Trockensubstanz zur Injektionsbereitung, 1 Stück limited | Baxter Healthcare GmbH | 26 Jan 2026 | 31 Mar 2027 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Holoxan 2 g - Trockensubstanz zur Injektionsbereitung, 1 Stück limited | Baxter Healthcare GmbH | 26 Jan 2026 | 31 Mar 2027 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).